Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related CLVS
Clovis Oncology Initiates Rolling NDA Submission to the FDA for Rociletinib in the Treatment of Advanced EGFR-Mutant Non-small Cell Lung Cancer
16 Biotech Stocks Moving Off The ASCO Conference
Related
Mid-Afternoon Market Update: Markets Continue to Rally as InfoBlox Takes a Big Haircut
Mid-Day Market Update: Dow Rises Over 1%; Cadence Pharma Shares Gain On Acquisition News

Clovis Oncology (NASDAQ: CLVS) shares fell 47.28% to $11.33 in the pre-market trading. Clovis Oncology reported negative outcome of CO-101 in pivotal LEAP pancreatic cancer study.

Star Scientific (NASDAQ: STSI) shares dropped 10.94% to $2.28 in pre-market trading. Star Scientific reported its Q3 net profit of $0.4 million, versus a year-ago net loss of $6.6 million.

J. C. Penney Company (NYSE: JCP) dipped 2.66% to $20.09 in the pre-market session. J. C. Penney reported Q3 loss.

Randgold Resources Limited (NASDAQ: GOLD) dipped 1.25% to $110.94 in the pre-market session. Randgold Resources' PEG ratio is -6.39.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (GOLD + CLVS)

Around the Web, We're Loving...

Get Benzinga's Newsletters